In the last trading session, 1.62 million 89bio Inc (NASDAQ:ETNB) shares changed hands as the company’s beta touched 1.50. With the company’s per share price at $7.40 changed hands at $0.46 or 6.63% during last session, the market valuation stood at $1.08B. ETNB’s last price was a discount, traded about -60.0% off its 52-week high of $11.84. The share price had its 52-week low at $4.16, which suggests the last value was 43.78% up since then. When we look at 89bio Inc’s average trading volume, we note the 10-day average is 1.22 million shares, with the 3-month average coming to 2.63 million.
Analysts gave the 89bio Inc (ETNB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.36. If we narrow down to specifics, the data shows that 0 out of 8 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 0 recommended ETNB as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. 89bio Inc’s EPS for the current quarter is expected to be -0.5.
89bio Inc (NASDAQ:ETNB) trade information
Instantly ETNB was in green as seen at the end of in last trading. With action 18.02%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -5.37%, with the 5-day performance at 18.02% in the green. However, in the 30-day time frame, 89bio Inc (NASDAQ:ETNB) is -17.41% down. Looking at the short shares, we see there were 17.03 million shares sold at short interest cover period of 6.9 days.
The consensus price target for the stock as assigned by Wall Street analysts is 25, meaning bulls need an upside of 70.4% from its current market value. According to analyst projections, ETNB’s forecast low is 12 with 29 as the target high. To hit the forecast high, the stock’s price needs a -291.89% plunge from its current level, while the stock would need to soar -62.16% for it to hit the projected low.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.21%. The 2025 estimates are for 89bio Inc earnings to increase by 42.05%, but the outlook for the next 5-year period is at 18.45% per year.
ETNB Dividends
89bio Inc is expected to release its next quarterly earnings report on 2025-Feb-26.
89bio Inc (NASDAQ:ETNB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.00% of 89bio Inc shares while 93.86% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 94.81%. There are 93.86% institutions holding the 89bio Inc stock share, with RA CAPITAL MANAGEMENT, L.P. the top institutional holder. As of 2024-06-30, the company held 14.1994% of the shares, roughly 14.18 million ETNB shares worth $113.54 million.
JANUS HENDERSON GROUP PLC holds the second largest percentage of outstanding shares, with 13.2986% or 13.28 million shares worth $106.32 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 3.08 shares estimated at $22.79 million under it, the former controlled 2.11% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.01% of the shares, roughly 2.93 shares worth around $21.66 million.
